CIK: 0001388551 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value ($000): $98,249 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | STRONGBRIDGE BIOPHARMA PLC | 5,514,994 | $38,053 | 38.7% | $2.51 | — | SHS USD | G85347105 |
| SPY | SPDR S&P 500 ETF TR | 77,052 | $19,358 | 19.7% | — | — | Put | 78462F103 |
| — | KALA PHARMACEUTICALS INC | 544,220 | $12,430 | 12.7% | $22.84 | — | COM | 483119103 |
| — | AGILE THERAPEUTICS INC | 1,820,012 | $8,117 | 8.3% | $6.12 | — | COM | 00847L100 |
| — | GARRISON CAP INC | 850,000 | $7,166 | 7.3% | $8.52 | — | COM | 366554103 |
| — | MOLECULAR TEMPLATES INC | 1,013,787 | $7,066 | 7.2% | $6.97 | — | COM | 608550109 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 8,945 | $1,640 | 1.7% | $132.86 | +33.0% | CL B NEW | 084670702 |
| JBGS | JBG SMITH PPTYS | 36,129 | $1,236 | 1.3% | $34.21 | — | COM | 46590V100 |
| — | INTEC PHARMA LTD JERUSALEM | 76,139 | $681 | 0.7% | $8.94 | — | SHS | M53644106 |
| — | CM FIN INC | 61,429 | $574 | 0.6% | $9.47 | — | COM | 12574Q103 |
| — | GTX INC DEL | 62,869 | $531 | 0.5% | $8.45 | — | COM NEW | 40052B207 |
| ADNT | ADIENT PLC | 4,737 | $398 | 0.4% | $50.50 | +38.0% | ORD SHS | G0084W101 |
| — | TEAM HEALTH HOLDINGS INC | 7,709 | $335 | 0.3% | $43.46 | — | COM | 87817A107 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1,997 | $306 | 0.3% | $130.25 | +16.1% | SHS USD | G50871105 |
| ACRS | ACLARIS THERAPEUTICS INC | 10,176 | $263 | 0.3% | $25.50 | +5.1% | COM | 00461U105 |
| — | MARINUS PHARMACEUTICALS INC | 16,198 | $95 | 0.1% | $5.86 | — | COM | 56854Q101 |